Back to top
more

CVS Health (CVS)

(Delayed Data from NYSE)

$66.63 USD

66.63
12,908,298

-0.22 (-0.33%)

Updated Oct 11, 2024 04:00 PM ET

After-Market: $66.63 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 7% (233 out of 250)

Industry: Retail - Pharmacies and Drug Stores

Better trading starts here.

Zacks News

John Blank headshot

Will Central Banks Start to Care About Fundamentals?

Macro-data has been much stronger than expected.¿¿¿¿¿¿ Still, the only thing that matters is NOT whether stock traders (or pundits) take note of strong data. It is whether the Fed and other major central banks care.

Mark Vickery headshot

Markets Up to Start Another Busy Week

With Q1 earnings season continuing to unfold favorably (for the most part), investors look to enjoy a healthy Q2, as well.

Is a Beat in the Cards for CVS Health (CVS) in Q1 Earnings?

Given the increasing number of walk-in-clinical appointments and patient visits, CVS Health (CVS), which has a huge PBM client base, is expected to have seen a sequential rebound in Q1 revenues.

CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $75.75, marking a -0.39% move from the previous day.

CVS Health (CVS) Stock Moves -0.17%: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $75.75, marking a -0.17% move from the previous day.

The Zacks Analyst Blog Highlights: Home Depot, Toyota, International Business Machines, Merck and CVS Health

The Zacks Analyst Blog Highlights: Home Depot, Toyota, International Business Machines, Merck and CVS Health

Sheraz Mian headshot

Top Research Reports for Home Depot, Toyota & IBM

Today's Research Daily features new research reports on 16 major stocks, including The Home Depot (HD), Toyota Motor (TM), and International Business Machines (IBM).

CVS Health (CVS) Gains As Market Dips: What You Should Know

CVS Health (CVS) closed the most recent trading day at $74.46, moving +0.53% from the previous trading session.

Magellan (MGLN) Expands in Precision Oncology With Trapelo

Magellan Health (MGLN) partners Trapelo Health to offer an all-inclusive approach to value-based care in the innovative arena of precision oncology treatments.

CVS Health (CVS) Extends COVID-19 Antibody Testing Nationwide

CVS Health's (CVS) antibody test detects for previous infection to COVID-19 and provides results within 15 minutes.

CVS Health (CVS) Gains But Lags Market: What You Should Know

CVS Health (CVS) closed the most recent trading day at $75.04, moving +0.7% from the previous trading session.

Why the Earnings Surprise Streak Could Continue for CVS Health (CVS)

CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

CVS Health (CVS) Stock Moves -0.29%: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $76.08, marking a -0.29% move from the previous day.

CVS Health (CVS) Gains As Market Dips: What You Should Know

CVS Health (CVS) closed the most recent trading day at $73.21, moving +1.82% from the previous trading session.

Why Is CVS Health (CVS) Up 1.8% Since Last Earnings Report?

CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know

CVS Health (CVS) closed at $74.01 in the latest trading session, marking a -1.41% move from the prior day.

CVS Health (CVS) Extends COVID-19 Testing in Massachusetts

CVS Heath's (CVS) antibody testing to be available in nearly 60 MinuteClinic locations and cost $38.

CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $72.35, marking a -0.48% move from the previous day.

Zacks Industry Outlook Highlights: CVS Health, Walgreen Boots, Herbalife, Rite Aid and Amazon

Zacks Industry Outlook Highlights: CVS Health, Walgreen Boots, Herbalife, Rite Aid and Amazon

Magellan's (MGLN) Q4 Earnings Miss Estimates, Decline Y/Y

Magellan Health's (MGLN) results reflect a decline in earnings and revenues due to lower contribution from Healthcare and Pharmacy Management units.

Urmimala Biswas headshot

3 Pharmacies & Drugstore Stocks to Watch Amid COVID-19 Resurgence

Despite severe COVID-19 challenges, higher demand for telemedicine and federal collaborations for vaccine rollout are likely to lend support to the Zacks Retail - Pharmacies and Drug Stores industry. HLF is well positioned to gain now while CVS and RAD hold huge prospects.

The Zacks Analyst Blog Highlights: Berkshire Hathaway, Walmart, Home Depot, CVS Health and Booking Holdings

The Zacks Analyst Blog Highlights: Berkshire Hathaway, Walmart, Home Depot, CVS Health and Booking Holdings

Mark Vickery headshot

Top Research Reports for Berkshire Hathaway, Walmart & Home Depot

Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway (BRK.B), Walmart (WMT) and Home Depot (HD).

CVS Health (CVS) Q4 Earnings Top Estimates but Decline Y/Y

The pandemic affects CVS Health's (CVS) fourth-quarter revenues in the Pharmacy Services segments as new therapy prescriptions reduce due to lower provider visits.

Magellan Health (MGLN), Wellth Tie Up on Behavioral Change

Magellan Health (MGLN) initiates a pilot program with Wellth to improve medication adherence and the general health of its members.